Rivaroxaban

Rivaroxaban (CAS No: 366789-02-8) is manufactured by Amber Lifesciences Pvt. Ltd. in advanced GMP and ISO 9001:2015 certified production units, ensuring premium purity, batch-to-batch consistency, and full compliance with international regulatory requirements. Each batch is supplied with a comprehensive Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), adhering to USP/EP pharmacopeial standards.

Rivaroxaban is an oral, direct Factor Xa inhibitor used as an anticoagulant in the prevention and treatment of thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke prevention in atrial fibrillation patients. Our API undergoes rigorous quality control processes and validated manufacturing methods to ensure dependable performance in various pharmaceutical formulations.

Amber Lifesciences supports pharmaceutical manufacturers, importers, distributors, and formulation developers across Asia, Europe, the Middle East, and LATAM regions, offering reliable supply chains, expert technical assistance, and complete regulatory documentation to expedite product registration and market entry.

Storage & Transportation

Classified as non-Dangerous Goods. Store at controlled room temperature (20°C to 25°C / 68°F to 77°F), protected from light and moisture. Follow standard pharmaceutical handling practices during shipping and storage.